Demands by institutional investors are blocking the visual and hearing impairment device developer's recovery plan. OrCam, a company that develops devices for visual and hearing impairments, is facing a serious dispute with institutional investors, delaying its recovery plan. The company had planned to spin off a company and raise funds to recover from competition and a decline in revenue. However, key investors are refusing to participate in the funding round, reducing the company's available capital. The investors have demands for full protection against dilution of their shares, making it difficult for OrCam to raise additional capital.